3'-(2Z)-1-(3,4-dÃmetÃ½lfenÃ½l)-1,5-dÃhÃ½drÃ³-3-metÃ½l-5-oxÃ³-4H-pÃ½rasÃ³l-4-Ã½lÃden hÃ½drasÃnÃ³-2'-hÃ½droxÃ½-1,1'-bÃfenÃ½l-3-karboxÃ½lsÃ½ru bis-(mÃ³nÃ³etanÃ³lamÃn),申请号IS20040007573-传众专利搜索

发明名称	3'-(2Z)-1-(3,4-dÃmetÃ½lfenÃ½l)-1,5-dÃhÃ½drÃ³-3-metÃ½l-5-oxÃ³-4H-pÃ½rasÃ³l-4-Ã½lÃden hÃ½drasÃnÃ³-2'-hÃ½droxÃ½-1,1'-bÃfenÃ½l-3-karboxÃ½lsÃ½ru bis-(mÃ³nÃ³etanÃ³lamÃn)
摘要	An improved thrombopoietin mimetic, the bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1-biphenyl]-3-carboxylic acid.
申请公布号	IS2770(B)	申请公布日期	2011.12.15
申请号	IS20040007573	申请日期	2004.11.30
申请人	GLAXOSMITHKLINE LLC	发明人	STEPHEN MOORE
分类号	A61P7/02;C12N5/06;A61K31/4152;A61K45/00;A61P7/06;A61P43/00;C07D231/08;C07D231/38;C07D231/46	主分类号	A61P7/02
代理机构		代理人
主权项
地址